DalsnaFinance › IPOs › Crinetics Pharmaceuticals Inc › IPO
Crinetics Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on July 18, 2018, pricing at $17.00 a share.
| Ticker | CRNX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 18, 2018 |
| Offering price | $17.00 |
| Shares offered | 6,000,000 |
| Total raised | $102M |
Crinetics Pharmaceuticals, Inc. sold 6,000,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $102 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $102 million total recorded for the deal.
Crinetics Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Crinetics Pharmaceuticals, Inc.. This page is general information, not investment advice.